clot chronicles: new fda approval for rivaroxaban
Published 5 years ago • 275 plays • Length 3:36Download video MP4
Download video MP3
Similar videos
-
4:38
clot chronicles: doac use in challenging patient cases
-
5:45
clot chronicles: periprocedural anticoagulation
-
3:09
clot chronicles - commander hf trial
-
3:18
new fda-approved clot removal devices show promise for treating stroke patients
-
3:00
fda approves rivaroxaban
-
3:00
news archive | fda approves rivaroxaban
-
3:35
hf 2022: deliver extends benefits of dapagliflozin to the full spectrum of pts with hf
-
0:44
the recent fda approval of ponatinib for ph all following success in the phallcon trial
-
8:01
fda d.i.s.c.o.: fda approval of cablivi for acquired thrombotic thrombocytopenic purpura
-
7:37
rivaroxaban: the game changing anticoagulant that's revolutionizing medical treatment
-
2:09
blood clots: what can i do to reduce my risks?
-
3:05
alliance a021501: preoperative mfolfirinox /- hypofractionated rt for pancreatic cancer
-
2:24
dr sonneveld on the fda approval of subcutaneous daratumumab plus vrd in myeloma
-
1:36
insights into pemigatinib and the recent fda approval of this agent
-
1:20
fda clears $3.5 million drug for hemophilia
-
6:30
bleeding risks, antidotes and future research for rivaroxaban
-
1:40
fda approves traumagel gel for medical professionals
-
2:56
rivaroxaban patient counseling
-
11:56
is rivaroxaban safe as long-term prevention for deep-vein thrombosis?